The present invention provides processes, methods and intermediates for
the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine,
salts, hydrates and crystal forms thereof which are useful as serotonin
(5-HT) receptor agonists for the treatment of, for example, central
nervous system disorders such as obesity.